NEW YORK (GenomeWeb News) – Beckman Coulter has inked a deal to be exclusive distributor outside of North America for IntelliCyt's HyperCyt system, an automated platform for multiplex cell- and bead-based screening.

Beckman also will hold co-exclusive distribution rights to the system in North America for use on its own CyAn flow cytometer. Beckman said that the combination will "create the fastest available flow cytometric cell analysis system."

Albuquerque, NM-based IntelliCyt will continue to provide direct sales and support of its HyperCyt system in North America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.